GLP3-R + Cagrilintide Blend
Price Range
Price varies
Vendors
0
Views
28
Where to Buy
Compare GLP3-R + Cagrilintide Blend prices across verified vendors. Affiliate links support Pushing Peptides.
We're gathering pricing data for GLP3-R + Cagrilintide Blend. Check back soon.
Overview
This blend combines Retatrutide (GLP3-R) with Cagrilintide, pairing a triple-agonist GIP/GLP-1/glucagon peptide with a long-acting amylin analog. The combination targets four distinct metabolic pathways simultaneously, representing one of the most comprehensive multi-receptor approaches in metabolic research.
Mechanism of Action
Retatrutide provides GIP, GLP-1, and glucagon receptor activation for appetite reduction, insulin sensitization, and hepatic fat oxidation. Cagrilintide adds amylin receptor agonism, which slows gastric emptying, suppresses glucagon secretion, and reduces food intake through hindbrain satiety centers. The four-pathway combination addresses appetite, insulin dynamics, energy expenditure, and gastric motility.
Research Context
This blend is inspired by Novo Nordisk's clinical development of CagriSema (cagrilintide + semaglutide), which showed exceptional weight loss results in trials. Substituting retatrutide for semaglutide adds glucagon receptor activity to the combination.
Key Research Areas
Considerations for Researchers
Small vendor base (10 vendors) reflects the novelty of this combination. Verify exact component ratios. Higher price point. Store at -20C.
Learn more about GLP3-R + Cagrilintide Blend
Research articles and guides
GLP3-R + Cagrilintide Blend: Research Uses & Lab Protocols
Discover how the GLP3-R + Cagrilintide blend is applied in weight loss research, with a focus on lab protocols and practical uses.
GLP3-R + Cagrilintide Blend: Mechanism of Action Explained
Explore the science behind the GLP3-R + Cagrilintide blend, detailing its dual-action molecular mechanisms for weight loss and metabolic health.
GLP3-R + Cagrilintide Blend: Research Overview & Findings
This post provides a comprehensive overview of the GLP3-R + Cagrilintide blend, summarizing recent studies and findings in peptide research.
Disclaimer: All information on this page is for research purposes only and is not intended as medical advice. Peptide research should be conducted by qualified professionals in appropriate laboratory settings. Pushing Peptides does not sell peptides. We aggregate publicly available pricing and vendor data.